What is ESWT (Extracorporeal Shockwave Therapy) and How Does It Work?
Extracorporeal Shockwave Therapy (ESWT) is based on the principle of focusing high-energy acoustic waves, generated from an external source, onto target tissues using a specialized applicator. Unlike radial systems, focused ESWT used in urological applications delivers acoustic energy directly to the targeted deep tissue layers. These shockwaves generate micro-mechanical stress in the treated area, triggering a cascade of biological responses at the cellular level.
The primary mechanism of action is the stimulation of neovascularization, or new blood vessel formation. The acoustic waves trigger the release of angiogenic factors such as Nitric Oxide (NO) and Vascular Endothelial Growth Factor (VEGF) from the vessel walls. This biological cascade permanently improves blood circulation and oxygenation in the target tissue, facilitating tissue repair and regeneration.
Technical Features of Advanced ESWT Devices
State-of-the-art ESWT systems preferred in modern clinical protocols are equipped with electromagnetic or electrohydraulic shockwave generators. The most prominent feature of these devices is the precise adjustment of penetration depth and energy flux density. This ensures that energy is delivered solely to the target anatomical structures (such as the corpora cavernosa or the prostatic region) without damaging surrounding healthy tissues.
- Focused Shockwaves (FSWT): Delivers energy directly to the tissue focal point at a specific depth without dispersion, maximizing cellular regeneration.
- Wide Focal Zone: Enhances patient comfort and shortens treatment duration by providing a homogenous energy distribution.
- Precise Energy Control: Allows fine-tuning of the energy flux density (mJ/mm²) based on patient tolerance and the specific indication.
ESWT Protocols in Urology: Key Indications
ESWT is among the primary non-invasive treatment options particularly for vasculogenic erectile dysfunction (ED), Peyronie's disease (penile plaques and curvature), and chronic pelvic pain syndrome (chronic non-bacterial prostatitis). The energy levels, number of shocks, and focal depths vary depending on the specific indication.
- Vasculogenic Erectile Dysfunction: Focused shockwaves are applied to different anatomical areas of the penis (the bilateral corpora cavernosa and the crura) to enhance microcirculation. High success rates are typically achieved in patients with mild to moderate vascular insufficiency.
- Peyronie's Disease: Shockwaves are focused directly onto the fibrotic plaques to stabilize plaque structure, alleviate pain, and reduce plaque volume.
- Chronic Pelvic Pain Syndrome: Shockwaves directed from the perineal region to the prostatic bed aim to reduce inflammation, relieve muscle spasms, and block chronic pain pathways.
Treatment Protocols and Session Parameters
Standard treatment protocols based on clinical trials are tailored to the patient's specific pathology. In the treatment of erectile dysfunction, protocols typically consist of 4 to 6 sessions, performed once or twice a week. During each session, approximately 1500 to 3000 shockwaves are distributed across the targeted anatomical regions. The procedure is entirely painless and does not require anesthesia or sedation.
Patients do not need to interrupt their daily activities during or after the treatment course. With an exceptionally low side-effect profile, no complications are expected other than mild, transient redness. Maximum clinical response is observed between 4 to 12 weeks post-treatment, coinciding with the completion of the neovascularization process.